Abstract. Matrix metalloproteinase-9 (MMP-9), which degrades the extracellular matrix (ECM), plays an important role in breast cancer pathogenesis. Previously, we reported that the Radix clematidis extract (RCE) inhibits MMP expression by suppressing the nuclear factor-κB (NF-κB) pathway. The purpose of the present study was to investigate the effects of RCE on 12-O-tetradecanoyl phorbol-13-acetate (TPA)-induced MMP-9 expression and cell invasion in MCF-7 cells. The toxicity of RCE was determined by MTT assay. MMP-9 expression was determined by real-time PCR, zymography and Western blot analysis. NF-κB activation was assayed by electrophoretic mobility shift assay (EMSA). Results showed that the expression of MMP-9 and cell invasion in response to TPA was increased, whereas TPA-induced MMP-9 expression and cell invasion was decreased by RCE. Moreover, RCE suppressed NF-κB activation in TPA-treated MCF-7 cells. Thus, RCE is a potent inhibitor of TPA-induced MMP-9 expression and markedly blocks the NF-κB pathway in MCF-7 cells.
Introduction
Radix clematidis is the name given to the root of Clematis florida T HUNB , a member of the Ranuncluaceae family. Radix clematidis is commonly used in traditional Chinese medicine for rheumatoid arthritis, gout, lower back and limb pain, strokes, headaches, congestion, promotion of urination, menstrual complications, and tonsillitis. Radix clematidis extract (RCE) possess high concentrations of pharmaceutical active isoflavonoids, including quercetin and kaempferol (1) . RCE has been found to induce suppression of the nuclear factor-κB (NF-κB) signaling pathway (2, 3) . It is well known that NF-κB is a transcription factor of significance to the regulation of MMP-9, as the promoter of matrix metalloproteinase-9 (MMP-9) gene contains binding sites for NF-κB (4) . Therefore, it was hypothesized that RCE possesses anticancer properties that inhibit cell invasion.
Breast cancer is a leading cause of malignancy-related deaths in females (5) . Most cases of breast cancer-related death are caused by distant metastasis to areas including the bone, lung, liver, kidney, thyroid and brain (6) . Invasion and metastasis are the fundamental characteristics and major causes of morbidity and mortality in breast cancer patients. These processes require degradation of the extracellular matrix (ECM), which provides biochemical and mechanical barriers to cell movement in cancer cells (7) . The ECM consists of type IV collagen, laminin, heparan sulfate proteoglycan, nidogen and fibronectin (8) . ECM degradation requires extracellular proteinases, of which the matrix metalloproteinases (MMPs) have been shown to play a critical role in breast cancer.
MMPs are a family of zinc-and calcium-dependent endopeptidases, constituting four subclasses based on substrate, including collagenases, gelatinases, stromelysins and membrane-associated MMPs. MMP-9 is reported to be a key enzyme for degrading type IV collagen, which is a major component of the basement membrane. Elevated MMP-9 levels are functionally linked to elevated metastasis in a number of tumors, including those of the brain (9), prostate (10), bladder (11) and breast (12, 13) . Several mechanisms regulate MMP-9 activity, including gene transcription, proenzyme activation, and endogenous inhibitors such as tissue inhibitors of metalloproteinases (TIMPs). A variety of stimuli, including cytokines and phorbol ester, stimulate MMP-9 synthesis and secretion during various pathological processes such as tumor invasion, atherosclerosis, inflammation, and rheumatoid arthritis. MMP-2, on the other hand, is usually expressed constitutively (13, 14) . Cytokine and 12-O-tetradecanoyl phorbol-13-acetate (TPA) treatments are capable of inducing MMP-9 expression via the activation of transcription factors such as NF-κB and activator protein-1 (AP-1) (15) (16) (17) . Consequently, inhibiting MMP-9 expression and/or its upstream regulatory pathways is critical to the treatment of malignant tumors, including breast carcinoma.
The purpose of this study was to examine the effects of RCE on TPA-induced MMP-9 expression and cell invasion in MCF-7 cells, a breast cancer cell line.
Materials and methods
Cells and materials. MCF-7 cells were obtained from the American Type Culture Collection (Manassas, VA, USA). Cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% antibiotics at 37˚C in a 5% CO 2 incubator. 12-O-tetradecanoyl phorbol-13-acetate (TPA) and 3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT), dimethyl sulfoxide (DMSO) and anti-β-actin antibody were obtained from Sigma (St. Louis, MO, USA). Primary antibodies for MMP-9, p50, p65, PCNA, and horseradish peroxidase (HRP)-conjugated IgG were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). [a32-P]dCTP was obtained from Amersham (Buckinghamshire, UK). High glucose-containing DMEM, FBS and phosphate-buffered saline (PBS) were obtained from Gibco-BRL (Gaithersburg, ME, USA). MTT assay. The effect of RCE on MCF-7 cell viability was determined using an MTT assay. Briefly, cells were seeded to 2xl0 4 /well and allowed to attach. After 24 h, cells were treated with various RCE concentrations (10, 50, 100 and 200 µg). After incubation for 24 h, cells were washed with PBS, MTT (0.5 mg/ml PBS) was added to each well and the plates were incubated at 37˚C for 30 min.Formazan crystals were dissolved with DMSO (100 µl/well) and detected at 570 nm using a microplate reader (Model 3550, Bio-Rad, Richmond, CA, USA). 5 ) were treated with RCE (50 and 100 µg) and TPA (100 nM) for 24 h. Cells were lysed with ice-cold M-PER ® mammalian protein extraction reagent (Pierce Biotechnology, Rockford, IL, USA). The protein concentration in the lysate was determined using the Bradford method (18) . Samples (20 µg) were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) with 10% acrylamide, and transferred to Hybond™-PVDF membranes using Western blot apparatus. The PVDF membranes were blocked with 5% skim milk and incubated overnight with 1 µg/ml primary antibodies for MMP-9, β-actin, p50, p65, or PCNA. HRP-conjugated IgG was used as a secondary antibody. Protein expression levels were determined by signal analysis using an image analyzer (Fuji-Film, Japan).
Preparation of RCE. Radix clematidis was obtained from
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Gelatin zymography assay. Conditioned media were collected after 24 h stimulation, mixed with non-reducing sample buffer, and electrophoresed in a polyacrylamide gel containing 0.1% (w/v) gelatin. The gel was washed at room temperature for 30 min with 2.5% Triton X-100 solution, and subsequently incubated at 37˚C for 16 h in 5 mM CaCl 2 , 0.02% Brij, and 50 mM Tris-HCl (pH 7.5). The gel was stained for 30 min with 0.25% (w/v) Coomassie brilliant blue in 40% (v/v) methanol/7% (v/v) acetic acid and visualized on an image analyzer (Fuji-Film, Japan). Proteolysis was imaged as a white zone in a dark blue field. Densitometric analysis was performed using Multi Gauge Image Analysis software (Fuji-Film).
Quantitative real-time PCR assay. Total RNA was extracted from cells using a FastPure™ RNA kit (Takara, Shiga, Japan). The RNA concentration and purity were determined by absorbance at 260/280 nm. cDNA was synthesized from 1 µg total RNA using a PrimeScript™ RT reagent kit (Takara). MMP-9 and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA expression were determined by real-time PCR using the ABI PRISM 7900 sequence detection system and SYBR ® -Green (Applied Biosystems, Foster City, CA, USA). The primers were: MMP-9 (NM 004994) sense, CCTGGAGACCTGAGAACCAATCT and antisense, CCACCCGAGTGTAACCATAGC, and GAPDH (NM 002046) sense, ATGGAAATCCCATCACCATCTT, and antisense, CGCCCCACTTGATTTTGG. To control for variation in mRNA concentration, the results were normalized to the housekeeping gene, GAPDH. Relative quantitation was performed using the comparative ∆∆C t method according to the manufacturer's instructions.
Preparation of nuclear extract. MCF-7 cells (2x10 6 ) were treated with RCE in the presence or absence of TPA for 4 h. Cells were immediately washed twice, scraped into 1.5 ml of ice-cold PBS (pH 7.5), and pelleted at 1,500 x g for 3 min. Cytoplasmic and nuclear extracts were prepared from cells using the NE-PER ® nuclear and cytoplasmic extraction reagents (Pierce Biotechnology). Electrophoretic mobility shift assay (EMSA). NF-κB activation was assayed with a gel mobility shift assay using nuclear extracts. An oligonucleotide containing the κ-chain (κB, 5'-CCGGTTAACAGAGGGGGCTTTCCGAG-3') binding site was synthesized and used as a probe for the gel retardation assay. The two complementary strands were annealed and labeled with [α-32 P]dCTP. Labeled oligonucleotides (10,000 cpm), 10 µg of nuclear extracts, and binding buffer [10 mM Tris-HCl, pH 7.6, 500 mM KCl, 10 mM EDTA, 50% glycerol, 100 ng poly (dI·dC), 1 mM DTT] were then incubated for 30 min at room temperature in a final volume of 20 µl. The reaction mixtures were analyzed by electrophoresis on 4% polyacrylamide gels in 0.5X Tris-borate buffer. The gels were dried and examined by autoradiography. Specific binding was controlled by competition with a 50-fold excess of cold κB oligonucleotide.
Invasion assay. The invasion assay was carried out in 24-well chambers (8 µm pore size) coated with 20 µl Matrigel-diluted DMEM. The Matrigel coating chambers were re-hydrated in 0.5 ml DMEM for 30 min immediately prior to the experiments. Cells (2x10 5 ) were added to the upper chamber, with chemoattractant in the bottom well. Conditioned medium (0.5 ml) was added to the lower compartment of the invasion chamber. The chambers were incubated for 24 h. After incubation, cells on the upper side of the chamber were removed using cotton swabs, and cells that had migrated were fixed and stained with Toluidine blue solution. Invading cells were counted in five random areas of the membrane using a light microscope. Analyzed data are the means ± SEM from three individual experiments performed in triplicate.
Statistical analysis. Statistical data analysis was performed using ANOVA and Duncan's test. Differences with p<0.05 were considered to be statistically significant.
Results
Effect of RCE on of MCF-7 cell viability.
To investigate the cytotoxicity of RCE on MCF-7 cells, the cells were seeded into 96-well culture plates at a density of 2x10 4 cells/well. The effect of RCE on MCF-7 cell toxicity was analyzed using the (Fig. 1) . Therefore, we performed experiments in optimal non-toxic concentrations (50 and 100 µg) of RCE with no change in morphology.
Effect of RCE on TPA-induced MMP-9 expression in MCF-7 cells.
To investigate the effect of RCE on TPA-induced MMP-9 expression, Western blot analysis, real-time PCR, and zymography were performed in MCF-7 cells. Western blot analysis revealed that RCE treatment of MCF-7 cells blocked the up-regulation of TPA-induced MMP-9 protein expression ( Fig. 2A) . Real-time PCR revealed that TPA increased the MMP-9 expression level in MCF-7 cells, and that RCE blocked TPA-induced MMP-9 up-regulation in a dose-dependent manner (Fig. 2B) . Zymography was performed to determine the effect of RCE on TPA-induced MMP-9 secretion. MCF-7 cell treatment with TPA resulted in increased MMP-9 secretion. RCE significantly diminished TPA-induced MMP-9 secretion (Fig. 2C) . These results indicate that RCE is a potent inhibitor of TPA-induced MMP-9 expression in MCF-7 cells.
Effect of RCE on TPA-induced NF-κB DNA binding activity.
To clarify the mechanism of RCE-mediated inhibition of MMP-9 expression, the effect of RCE on the TPA-induced activation of NF-κB was evaluated using EMSA. As shown in Fig. 3A , TPA substantially increased NF-κB binding activity. Treatment with RCE inhibited TPA-stimulated NF-κB binding activity. RCE itself had no effect on NF-κB binding activity. These results indicate that RCE specifically blocks TPA-induced NF-κB activation in MCF-7 cells. Under basal conditions, the cytoplasmic protein IκBα directly binds to p65 and p50 subunits and represses their nuclear translocation. Therefore, we determined the alteration of IκBα levels of the cytoplasmic fraction and p65 and p50 levels of the nuclear fraction in this study. TPA-stimulated MCF-7 cells exhibited a decreased level of IκBα protein in the cytoplasm and increased levels of p65 and p50 in the nuclear fraction when compared to a similar fraction in the unstimulated cells. However, the increased IκBα degradation and translocation of p65 and p50, a result of TPA stimulation, was significantly suppressed by treatment with RCE (Fig. 3B) .
Effect of RCE on TPA-induced MCF-7 cell invasion in vitro.
It has been reported that the up-regulation of MMP-9 expression contributes to the invasion of cancer cells (19, 20) . An in vitro invasion assay was used to investigate the inhibitory effects of RCE on the invasive potency of breast carcinoma MCF-7 cells. Treatment of TPA increased MCF-7 cell invasion when compared with untreated control cells. Incubation of MCF-7 cells with TPA resulted in a 10.5-fold increase in the invasion of MCF-7 cells. However, treatment with RCE significantly reduced the TPA-induced cell invasion by 82% (Fig. 4) .
Discussion
Our results show for the first time that RCE suppressed TPA-induced MMP-9 expression by blocking the NF-κB signaling pathways and that the suppression of MMP-9 expression was well correlated with its inhibition of cell invasion. Previous studies have demonstrated that NF-κB is a molecular target in RCE treated cells (15, 19) . Our findings showed the molecular mechanism of RCE, and that RCE blocked the TPA-mediated activation of NF-κB pathway.
Breast cancer is the leading cause of death from cancer in women worldwide. It is the second most frequent cause of death in women overall in the USA. Metastasis is the primary cause of breast cancer mortality. Tumor metastasis is a multistep process by which a subset of individual cancer cells disseminates from a primary tumor to distant secondary organs or tissues. This process involves cell proliferation, ECM degradation, cell migration, and tumor growth at metastatic sites (13, 15) . Tumor cell invasion is an early step in the metastatic cascade, representing the beginning of the transition from the benign stage to malignancy. Morphologically, tumor invasion is associated with a distorted edge of the primary tumor where individual or cohorts of tumor cells actively invade the tissue ECM surrounding the primary tumor (20) . MMP-9 is regarded as a critical molecule in processing tumor invasion and metastasis. MMP-9 activation has been revealed to be particularly associated with tumor progression and invasion, including that of mammary tumors (21) . In previous reports, inflammatory cytokines, growth factors, or phorbol esters were revealed to stimulate MMP-9 by activating different intracellular-signaling pathways in breast cancer cells (22) (23) (24) (25) . The inhibitory effect on MMP-9 expression is crucial for the development of a therapeutic experimental model of tumor metastasis.
NF-κB is a transcription factor of significance to the regulation of MMP-9, as the MMP-9 gene promoter contains binding sites for NF-κB (13) . NF-κB is an inducible dimeric transcription factor that belongs to the Rel/NF-κB family of transcription factors and consists of two major polypeptides, p65 and p50 (26) . NF-κB is initially located in the cytoplasm in a dormant form complexed with IκB, an inhibitory factor of NF-κB. Various inducers such as TPA, cytokines and stress can dissociate this complex, presumably by I-κB phosphorylation, resulting in the release of NF-κB from the complex. NF-κB then translocates to the nucleus, where it interacts with specific DNA recognition sites to mediate gene transcription. NF-κB elements are centrally involved in MMP-9 gene induction by TPA (15, 16) . Our results reveal that RCE inhibited MMP-9 expression by suppression of NF-κB in breast carcinoma cells.
In conclusion, our results have demonstrated that RCE is a potent inhibitor of TPA-induced MMP-9 expression and markedly blocks the ability of the NF-κB pathway in breast carcinoma cells. This is the first study revealing RCE suppression of TPA-stimulated cancer cell invasion by inhibiting MMP-9 expression. We also detailed the molecular mechanisms of the NF-κB pathway in breast cancer cells responsible for this inhibitory effect. Thus, RCE may be a potential candidate for the prevention of breast tumor invasion and metastasis in vivo.
